Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis

Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis

Abstract Background In three randomized, controlled laboratory efficacy studies, the efficacy in the prevention of patent infections of a topical combination of imidacloprid 10%/moxidectin 1% (Advocate® spot-on formulation for cats, Bayer Animal Health GmbH) against larval stages and immature adults...

Full description

Bibliographic Details
Main Authors: Lea Heuer, Gabriele Petry, Matthias Pollmeier, Roland Schaper, Katrin Deuster, Holger Schmidt, Katrin Blazejak, Christina Strube, Angela Di Cesare, Donato Traversa, Manuela Schnyder, Janina McKay-Demeler, Georg von Samson-Himmelstjerna, Sandra Mangold-Gehring, Claudia Böhm
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Parasites & Vectors
Subjects:
Aelurostrongylus abstrusus
Moxidectin
Feline lungworm
Prevention
Treatment
Online Access:https://doi.org/10.1186/s13071-020-3937-2

Internet

https://doi.org/10.1186/s13071-020-3937-2

Similar Items